Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-02-23
1997-09-23
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
544240, A61K 3150
Patent
active
056705042
ABSTRACT:
A class of 2,6-diarylpyridazinones of general structural formula I have been identified that exhibit exhibit immunosuppressant activity with human T-lymphocytes, and are useful as an immunosuppressants. ##STR1## or a pharmaceutically acceptable salt, hydrate or crystal form thereof
REFERENCES:
patent: 4820704 (1989-04-01), Richarz et al.
patent: 4910201 (1990-03-01), Kawamura et al.
patent: 4995091 (1991-02-01), Makabe
patent: 5169848 (1992-12-01), Bettarini
patent: 5202323 (1993-04-01), Tanikawa
patent: 5409956 (1995-04-01), Yoshida et al.
patent: 5462914 (1995-10-01), Leitner
patent: 5506228 (1996-04-01), Norton et al.
Elghandour, et al. Chem. Abstr vol. 122 Entry 81263 (1994).
Derwent Abstract of JP67/9344 (1967) AN-66-26853F, Class B.
Bochis Richard J.
Kotliar Andrew
Parsons William H.
Rupprecht Kathleen
Camara Valerie J.
Daniel Mark R.
Daus Donald G.
Merck & Co. , Inc.
LandOfFree
2,6-diaryl pyridazinones with immunosuppressant activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2,6-diaryl pyridazinones with immunosuppressant activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2,6-diaryl pyridazinones with immunosuppressant activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1938735